J&J expects to hit $100 billion in revenue next year after new strategy pays off
Johnson & Johnson sees revenue grow 9% in the fourth quarter, amid strength in its cancer drugs. www.marketwatch.com #JampJ #expects…
Johnson & Johnson sees revenue grow 9% in the fourth quarter, amid strength in its cancer drugs. www.marketwatch.com #JampJ #expects…
Source: Bloomberg, 4:53 www.bloomberg.com #Stock #Movers #Novo #Nordisk #JampJ #ServiceNow #Podcast
Source: Bloomberg, 3:36 www.bloomberg.com #Stock #Movers #JampJ #Prologis #Global #Payments #Podcast